Scientist.com has launched Clinical Labs Navigator, a new tool for sourcing, managing, and executing services for clinical trials.
This tool helps streamline workflows, enhance communication, and promote transparency throughout the clinical research lifecycle.
Go deeper with GlobalData
According to the company, it is tailored to meet the demands of life science organisations, offering a “compliant and connected” workflow.
The navigator tool addresses several “high impact” areas for both sponsors and contract research organisations (CROs). These include budget digitisation, built-in cost modelling tools, improved audit trails, and analytics.
These advancements aim to refine budget accuracy and increase compliance.
The solution is especially beneficial for organisations looking to “consolidate” sourcing efforts, minimise trial delay periods, and enhance visibility throughout worldwide clinical operations. It claims to remove the complex trial design’s inefficiencies.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataWith this tool’s introduction, the company broadens its clinical-stage portfolio, now providing solutions across the whole development pipeline.
This includes real-world evidence/data (RWE/RWD), health economics and outcomes research (HEOR), market access, good manufacturing practice (GMP) manufacturing, and late-stage biomarker development.
Scientist.com compliance and categories senior vice-president Matt McLoughlin said: “Clinical Labs Navigator was built to meet the increasing need for integrated, efficient, and compliant solutions in clinical trial execution.
“We’ve created a tool that not only helps clients streamline the design of clinical trials, through enhanced internal and external collaboration, but increases transparency throughout the study design and contracting process.”
By utilising AI-enabled tools and embedded compliance frameworks, the platform enables procurement professionals and researchers to make quick decisions, thereby expediting therapy development.
